26 mg (10%) and a stirring bar were charged in a two neck
round-bottomed flask equipped with a condenser and the setup
was degassed and back-filled three times with a gaseous mixture
of Ar + H2. THF (8–10 mL) was introduced via a syringe into
the reaction flask followed by 6 equivalent of TEA and finally by
a solution of the terminal acetylene (1.1 mmol) [4-tolylacetylene
(Aldrich) 127 mg] in 5 mL THF via a syringe under the mild
reducing atmosphere at about 60 °C. After the addition of the
alkyne, the reaction mixture was refluxed for 8–10 h. When
the TLC indicated disappearance of starting compounds, the
volatiles were evaporated and the residue was recrystallized
from toluene to get pure 2 as yellow crystals 222 mg (76%); mp:
156–158 °C; 1H NMR (400 MHz, CDCl3): d 8.55 (d, J 8.4 Hz,
2H), 8.23 (d, J 8.8 Hz, 2H), 7.79 (t, J 7.6 Hz, 2H), 7.67 (d, J 8.4
Hz, 2H), 7.61 (t, J 7.5 Hz, 2H), 7.27 (d, J 7.6 Hz, 2H), 2.43 (s,
3H); 13C NMR (100 MHz, CDCl3): d 148.76, 140.35, 132.29,
130.73, 130.11, 129.80, 128.66, 127.10, 126.84, 126.81, 119.70,
106.14, 84.09, 22.32; High Mass (M+) m/z: 293.1205 calculated
for C22H15N: 293.1204.
Scheme 1 Structures of phenylethynylacridines prepared and used in
the present study.
9-Phenylethynyl-acridine (1). Mp: 164–165 °C; 1H NMR
(400 MHz, CDCl3): d 8.55 (d, J 8.4 Hz, 2H), 8.24 (d, J 8.8 Hz,
2H), 7.79 (m, 4H), 7.62 (t, J 7.5 Hz, 2H), 7.46 (m, 3H); 13C
NMR (100 MHz, CDCl3): d 148.75, 132.32, 130.66, 130.16,
129.86, 128.99, 128.21, 126.97, 126.86, 126.82, 122.73, 105.56,
84.53; High Mass (M+) m/z: 279.1028 calculated for C21H13N:
279.1048.
Experimental
All the chemicals and reagents were purchased from Acros
Organics, unless specified otherwise, and were used as received.
Dichlorobis(triphenylphosphine)palladium(II)
was
either
prepared in-house or from commercial source (Acros).
9-Chloroacridine was prepared from N-phenylanthranilic acid
and phosphoryl chloride according to the reported method.12
Solvents were distilled as per the standard methods and purged
with argon before use. Triethylamine (TEA) and tetrahydrofuran
(THF) were distilled and purged with a mixture of approxi-
mately 1:1 argon and hydrogen before use. 1H-NMR spectra of
the samples were recorded with a 400 MHz Varian instrument
and 13C-NMR spectra were recorded with the same instrument
at 100.1 MHz operator frequency in CDCl3 solvent (Merck) with
CHCl3 internal standard (d 7.24 ppm for 1H and 77 ppm, middle
of the three peaks, for 13C spectra. Mass spectra were recorded
with a JEOL SX 102A instrument on a nitrobenzyl alcohol
matrix. TLC was run on Merck precoated aluminium plates
(Si 60 F254). Column chromatography was run on Merck silica
gel (60–120 mesh) or neutral alumina (Merck) 70–230 mesh.
All UV-Visible spectra were recorded on a HITACHI U-2000
spectrophotometer with 10 lM solution of the compounds in
CH3CN and all fluorescence spectra on a HITACHI F-3010
fluorescence spectrophotometer using similar solution con-
centrations. Fluorescence quantum yields (U) were determined
in CH2Cl2 with reference to coumarin 1 standard (U = 0.5 in
MeOH).13 CV measurements were done on a CH Instruments
Electrochemical Analyzer. The cell used is a three-electrode
cell consisting of a carbon disc (2.0 mm) working electrode,
a platinum wire counter electrode and a Ag/AgCl reference
electrode. The scan rate was 100 mV s−1. ECL spectra were
recorded at room temperatures using a setup consisting of an
F-3010 Fluorescence spectrophotometer, a CV-27 Voltammo-
graph with a computer interface. The electrode surfaces were
prepared freshly before CV and ECL experiments. The carbon
disc electrode was rubbed against alumina paste and the Pt
electrode was cleaned by rinsing with dilute nitric acid followed
by water and then fired with a naked flame to ensure maximum
cleanliness of the electrode. Typically a 1 mM concentration of
the compound solution in degassed acetonitrile2b with 0.05 M
tetrabutylammonium perchlorate (TBAP) was used. To gener-
ate the annihilation reaction, the platinum electrode was pulsed
between the first reduction and first oxidation potentials and the
pulse interval was controlled on a computer. All measurements
were done at room temperature (22–23 °C).
9-(4-Methoxy-phenylethynyl)-acridine (3). Mp: 167–169 °C;
1H NMR (400 MHz, CDCl3): d 8.56 (d, J 8.8 Hz, 2H), 8.24 (d, J
8.8 Hz, 2H), 7.80 (t, J 8.6 Hz, 2H), 7.73 (d, J 8.8 Hz, 2H), 7.62
(t, J 8.6 Hz, 2H), 6.99 (d, J 8.8 Hz, 2H), 3.88 (s, 3H); 13C NMR
(100 MHz, CDCl3): d 160.89, 148.85, 133.95, 130.58, 130.19,
128.69, 127.08, 126.72, 126.64, 114.83, 114.69, 106.10, 83.68,
55.92; High Mass (M+) m/z: 309.1148 calculated for C22H15NO:
309.1154.
9-(4-Isopropoxy-phenylethynyl)-acridine (4). Mp: 145–147 °C;
1H NMR (400 MHz, CDCl3): d 8.54 (d, J 8.4 Hz, 2H), 8.21 (d, J
8.8 Hz, 2H), 7.78 (t, J 7.8 Hz, 2H), 7.69 (d, J 8.8 Hz, 2H), 7.60 (t,
J 7.4 Hz, 2H), 6.95 (d, J 8.8 Hz, 2H), 4.62 (septet, J 6.0 Hz, 1 H),
1.37 (d, J 6.4 Hz, 2H); 13C NMR (100 MHz, CDCl3): d 159.38,
148.85, 134.02, 130.65, 130.18, 128.88, 127.14, 126.76, 126.67,
116.31, 114.40, 106.36, 83.58, 70.59, 22.57; High Mass (M+) m/z:
337.1471 calculated for C24H19NO: 337.1467.
9-[4-(2-Ethyl-hexyloxy)-phenylethynyl]-acridine (5). Pale
1
liquid; H NMR (400 MHz, CDCl3): d 8.53 (d, J 8.4 Hz, 2H),
8.21 (d, J 8.8 Hz, 2H), 7.77 (t, J 7.8 Hz, 2H), 7.69 (d, J 10.4 Hz,
2H), 7.59 (t, J 7.5 Hz, 2H), 6.96 (d, J 8.4 Hz, 2H), 3.89 (d, J
6.0 Hz, 2H), 1.75 (sextet, J 6.0 Hz, 1H), 1.46 (m, 4H), 1.32 (m,
4H), 0.91 (m, 6H); 13C NMR (100 MHz, CDCl3): d 160.84,
148.87, 133.94, 130.60, 130.19, 128.86, 127.13, 126.75, 126.65,
115.28, 114.50, 106.38, 83.63, 71.22, 39.91, 31.09, 29.68, 24.46,
23.64, 14.71, 11.76; High Mass (M+) m/z: 407.2240 calculated for
C29H29NO: 407.2249.
9-[4-(N,N-Dimethylamino)-phenyl]ethynyl-acridine (6). Mp:
230–232 °C; 1H NMR (400 MHz, CDCl3): d 8.56 (d, J 8.0 Hz,
2H), 8.20 (d, J 8.8 Hz, 2H), 7.77 (t, J 7.7 Hz, 2H), 7.64 (d, J
9.2 Hz, 2H), 7.58 (t, J 7.5 Hz, 2H), 6.72 (d, J 9.2 Hz, 2H), 3.04
(s, 6H); 13C NMR (100 MHz, CDCl3) d 151.19, 148.94, 133.76,
130.52, 130.11, 129.60, 127.33, 126.5, 126.33, 112.16, 109.17,
108.4, 83.59, 40.68; High Mass (M+) m/z: 322.1470 calculated
for C23H18N2: 322.1470.
Theoretical calculations
General procedure for the synthesis of 9-p-tolylethynylacridine (2)
Theoretical calculations were performed using Spartan’04™
for Windows, Wavefunction Inc., Irvine, CA 92612, USA.
Molecules were built and optimized at the B3LYP level of
9-Chloroacridine (prepared according to ref. 12) 213.7 mg
(1 mmol), (PPh3)2PdCl2 14 mg (2 mol%), CuI 4 mg (2%), PPh3
3 1 1 4
O r g . B i o m o l . C h e m . , 2 0 0 4 , 2 , 3 1 1 3 – 3 1 1 8